#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Asthma Spinal muscular atrophy Oesophageal squamous cell carcinoma stage II Glomerulonephritis B-cell lymphoma recurrent Hypersensitivity pneumonitis Plasma cell myeloma recurrent Cytomegalovirus infection Pulmonary sarcoidosis Myeloid leukaemia Mantle cell lymphoma refractory Hyperinsulinism Marginal zone lymphoma refractory Acute lymphocytic leukaemia Cutaneous calcification More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma metastatic – Diagnostics Lymphatic malformation – Trials in Disease Noonan syndrome – Basic Information Testicular leiomyosarcoma – Life with Disease Ewing’s sarcoma metastatic – Trials in Disease Isodicentric chromosome 15 syndrome – Treatment Mantle cell lymphoma stage IV – Treatment Hereditary motor and sensory neuropathy – Basic Information Piriformis syndrome Pituitary-dependent Cushing’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dermatophagoides Pteronyssinus Csm-Gw Metoclopramide Azd5462 Iopromide Gadoxetic Acid, Disodium Afamelanotide Lifileucel Glucagon Cemdisiran Deutivacaftor Rigosertib Sodium Trametinib Methyl Aminolevulinate ISPAGHULA HUSK ATTR-01 Emrusolmin MB-CART2219.1 Glucocorticoids Azd0305 More therapies…

    Learn about Your Condition

    Acoustic neuroma Wiskott-Aldrich syndrome Cirrhosis alcoholic Diabetic ketoacidosis Noninfective chorioretinitis Triple positive breast cancer Systemic infection Eye disorder Benign prostatic hyperplasia Rhinitis allergic Embolism Acute myeloid leukaemia Anaemia of chronic disease Acquired haemophilia Tendon rupture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Eivy Franke Beckmann

Eivy Franke Beckmann

Ammertalweg 7, Ilversgehofen, Erfurt, 99086, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Immune Response of MenACYW Conjugate Vaccine Compared to a Drug Combination in Healthy Infants and Toddlers

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Meningococcal infection
    Investigated Drugs:
    • Neisseria Meningitidis, Serogroup C, Polysaccharide, Conjugated To Tetanus Toxoid
    • N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
    • Neisseria Meningitidis Group A Polysaccharide Conjugated To Tetanus Toxoid Carrier Protein
    Czechia Denmark Finland Germany Poland Romania

  • Study on the Effect of a New Moisturiser with Paraffin and Liquid Paraffin on Preventing Eczema Relapse in Children

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Eczema
    • Dermatitis atopic
    Investigated Drugs:
    • Liquid Paraffin
    • Methylprednisolone Aceponate
    • Paraffin White Soft
    Germany Sweden

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!